The Impact of Genomic Changes on Treatment of Lung Cancer

by Cardarella, Stephanie, Johnson, Bruce E.
Published 2013

Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer

by Kehl, Kenneth L, Lathan, Christopher S, Johnson, Bruce E, Schrag, Deborah
Published in J Natl Cancer Inst (2018)

State of the Art: Response Assessment in Lung Cancer in the Era of Genomic Medicine

by Nishino, Mizuki, Hatabu, Hiroto, Johnson, Bruce E., McLoud, Theresa C.
Published in Radiology (2014)

Parity and Risk of Lung Cancer in Women

by Paulus, Jessica K., Asomaning, Kofi, Kraft, Peter, Johnson, Bruce E., Lin, Xihong, Christiani, David C.
Published 2010

Haplotypes of Estrogen Receptor Beta and risk of Non-small cell lung cancer in women

by Paulus, Jessica K., Zhou, Wei, Kraft, Peter, Johnson, Bruce E., Lin, Xihong, Christiani, David C.
Published 2010

Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer

by Cooley, Mary E., Wang, Qian, Johnson, Bruce E., Catalano, Paul, Haddad, Robert I., Bueno, Raphael, Emmons, Karen M.
Published 2011

Imaging of Lung Cancer in the Era of Molecular Medicine

by Nishino, Mizuki, Jackman, David M., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E., Van den Abbeele, Annick D.
Published 2011

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm

by Nishino, Mizuki, Wakai, Satoshi, Hida, Tomoyuki, Dahlberg, Suzanne E., Ozaki, Masahiro, Hatabu, Hiroto, Tachizaki, Hisashi, Johnson, Bruce E.
Published in Eur J Radiol (2018)

Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib

by Heon, Stephanie, Yeap, Beow Y., Britt, Gregory J., Costa, Daniel B., Rabin, Michael S., Jackman, David M., Johnson, Bruce E.
Published 2010

Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism

by Shinagare, Atul B., Okajima, Yuka, Oxnard, Geoffrey R., DiPiro, Pamela J., Johnson, Bruce E., Hatabu, Hiroto, Nishino, Mizuki
Published 2012

Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib

by Nishino, Mizuki, Dahlberg, Suzanne E., Fulton, Linnea E., Digumarthy, Subba R., Hatabu, Hiroto, Johnson, Bruce E., Sequist, Lecia V.
Published in Acad Radiol (2016)

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome

by Araki, Tetsuro, Dahlberg, Suzanne E., Hida, Tomoyuki, Lydon, Christine A., Rabin, Michael S., Hatabu, Hiroto, Johnson, Bruce E., Nishino, Mizuki
Published in Eur J Radiol Open (2019)

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome

by Park, Hyesun, Dahlberg, Suzanne E., Lydon, Christine A., Araki, Tetsuro, Hatabu, Hiroto, Rabin, Michael S., Johnson, Bruce E., Nishino, Mizuki
Published in Oncologist (2019)

Patient report of receipt and interest in smoking cessation interventions after a diagnosis of cancer

by Cooley, Mary E., Emmons, Karen M., Haddad, Robert, Wang, Qian, Posner, Marshall, Bueno, Raphael, Cohen, Tiffany-Jen, Johnson, Bruce E.
Published 2011

Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab

by Nishino, Mizuki, Cryer, Sarah K., Okajima, Yuka, Sholl, Lynette M., Hatabu, Hiroto, Rabin, Michael S., Jackman, David M., Johnson, Bruce E.
Published 2012

Tumor Volume Decrease at 8 weeks is Associated with Longer Survival in EGFR-mutant Advanced Non-Small-Cell Lung Cancer Patients treated with EGFR Tyrosine Kinase Inhibitor

by Nishino, Mizuki, Dahlberg, Suzanne E., Cardarella, Stephanie, Jackman, David M., Rabin, Michael S., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E.
Published 2013

RECIST 1.1 in NSCLC Patients With EGFR Mutations Treated With EGFR Tyrosine Kinase Inhibitors: Comparison With RECIST 1.0

by Nishino, Mizuki, Cardarella, Stephanie, Jackman, David M., Ramaiya, Nikhil H., Rabin, Michael S., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E.
Published 2013

Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs

by Lin, Jessica J., Cardarella, Stephanie, Lydon, Christine A., Dahlberg, Suzanne E., Jackman, David M., Jänne, Pasi A., Johnson, Bruce E.
Published in J Thorac Oncol (2015)

Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib

by Nishino, Mizuki, Hida, Tomoyuki, Kravets, Sasha, Dahlberg, Suzanne E., Lydon, Christine A., Hatabu, Hiroto, Johnson, Bruce E., Awad, Mark M.
Published in Eur J Radiol Open (2020)

Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes

by Ivanov, Sergey V., Kuzmin, Igor, Wei, Ming-Hui, Pack, Svetlana, Geil, Laura, Johnson, Bruce E., Stanbridge, Eric J., Lerman, Michael I.
Published 1998